MicroRNAs

From Basic Science to Disease Biology
Erscheinungsjahr 2011
ISBN: 978-0-521-86598-2
Verlag: Cambridge University Press

Buch, Englisch, 560 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 1271 g

MicroRNAs (miRNAs) are RNA molecules, conserved by evolution, that regulate gene expressions and their recent discovery is revolutionising both basic biomedical research and drug discovery. Expression levels of MiRNAs have been found to vary between tissues and with developmental stages and hence evaluation of the global expression of miRNAs potentially provides opportunities to identify regulatory points for many different biological processes. This wide-ranging reference work, written by leading experts from both academia and industry, will be an invaluable resource for all those wishing to use miRNA techniques in their own research, from graduate students, post-docs and researchers in academia to those working in R&D in biotechnology and pharmaceutical companies who need to understand this emerging technology. From the discovery of miRNAs and their functions to their detection and role in disease biology, this volume uniquely integrates the basic science with industry application towards drug validation, diagnostic and therapeutic development.

Autoren/Hrsg.

Appasani, Krishnarao

Weitere Mitwirkende

Altman, Sidney

Ambros, Victor R.

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften Genetik und Genomik (nichtmedizinisch)
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik

Inhaltsverzeichnis

Part I. Discovery of MicroRNAs in Various Organisms; Part II. MicroRNA Functions and RNAi-mediated pathways; Part III. Computational Biology of microRNAs; Part IV. Detection and Quantitation of MicroRNAs; Part V. MicroRNAs in Disease Biology; Part VI. MicroRNAs in Stem Cell Development.

Über Autor(innen)

Appasani, Krishnarao
Krishnarao Appasani is the Founder and Chief Executive Officer of Gene Expression Systems, a gene discovery company, focusing on functional genomics in cancer research. He is the Editor of RNA Interference: From Basic Science to Drug Development (2005).